| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Oct―09 |
In Silico Screening, In Vitro Mpro Inhibitory, and Adjunctive Therapy Value of Minocycline for the Treatment of COVID-19 |
Yaru Han, Xianxiang Bai, Si Wu, Xiurong Luan, Liwen Ren, Jinhua Wang, Zhanfei She, Bin Xiao, Guanhua Du, Samuel Silvestre |
| 2 |
[GO] |
2022―Aug―22 |
Antibiotic use during the first 6 months of
COVID
-19 pandemic in Iran: A large-scale multi-centre study |
Mohammadreza Salehi, Hossein Khalili, Arash Seifi, Hamidreza Davoudi, Ilad Alavi Darazam, Zahra Jahangard-Rafsanjani, Esmaeil Mohammadnejad, Behrooz Heydari, SaeedReza Jamali Moghadam Siahkaly, Payam Tabarsi, Saeed Kalantari, Seyed Ali Dehghan Menshadi, Farhang Babamahmoodi, Farzin Khorvash, Mohammad Ali Davarpanah, Rasool Soltani, Mojtaba Hedayat Yaghoobi, Seyed Alireza Mosavi Anari, Javad Khodadadi, Amir Aliramezani, Sedigheh Hantooshzadeh, Hamid Reza Naderi, Mahboobeh Hajiabdolbaghi, Sepideh Elyasi, Dena Firouzabadi, Hamideh Abbaspour Kasgari, Soheil Roshanzamiri, Sholeh Ebrahimpour |
| 3 |
[GO] |
2022―Jun―14 |
Critical care tele-pharmacy services during
COVID
-19 pandemic: A qualitative exploration of healthcare practitioners' perceptions |
Nour Isleem, Sadim Shoshaa, Ahmad AbuGhalyoun, Mohamad Khatib, Lina Mohammad Naseralallah, Mohammed Ibn-Mas'ud Danjuma, Mohamed Saad |
| 4 |
[GO] |
2022―May―28 |
SARS-CoV
-2 neutralizing antibodies for COVID-19: Outcomes for bamlanivimab versus
bamlanivimab-etesevimab
combination in a racially diverse cohort of patients with significant comorbidities |
Lea M. Monday, Indira Brar, George Alangaden, Mayur S. Ramesh |
| 5 |
[GO] |
2022―Mar―21 |
Incidence and risk factors for hyperkalaemia in patients treated for COVID-19 with nafamostat mesylate |
Kentaro Kodama, Toru Imai, Yasuo Asai, Yutaka Kozu, Kentaro Hayashi, Tetsuo Shimizu, Yasuhiro Gon, Susumu Ootsuka |
| 6 |
[GO] |
2022―Feb―07 |
Omicron variant as nature's solution to the COVID-19 pandemic |
Alain Li Wan Po |
| 7 |
[GO] |
2021―Dec―24 |
Does COVID-19 increase tacrolimus levels in kidney transplant recipients? |
Divya Bajpai, Nikhil Saxena, Chintan Gandhi, Tulsi Modi, Sreyashi Bose, Satarupa Deb, Nikhil Rao, Kruteesh Kumar, Abhinav Katyal, Ankita Patil, Sayali Thakare, Atim E. Pajai, Ashwathy Haridas, Vaibhav S. Keskar, Sunil Y. Jawale, Amar G. Sultan, Tukaram E. Jamale |
| 8 |
[GO] |
2021―Nov―12 |
Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia |
Archana Roy, Harry Ross Powers, Emily C. Craver, Mark D. Nazareno, Siva Naga S. Yarrarapu, Devang K. Sanghavi |
| 9 |
[GO] |
2021―Sep―04 |
Evaluation of a web-based educational programme for pharmacists during the COVID-19 pandemic in Japan |
Masami Tsuchiya, Hideyuki Terazono, Yosuke Maki, Naoki Yoshikawa, Yosuke Kawahara, Keiko Nishimura, Keisuke Shinohara, Daisuke Ogawa, Riho Mori, Yoshihiro Iwamoto, Fumio Itagaki, Hiroyuki Masuko, Masahito Yonemura, Mayako Uchida |
| 10 |
[GO] |
2021―Aug―25 |
Suboptimal plasma concentrations with posaconazole suspension as prophylaxis in critically ill COVID-19 patients at risk of Covid-associated pulmonary aspergillosis |
Paola Mian, Ronald J. Trof, Albertus Beishuizen, Joost B. Masselink, Alexander D. Cornet, Esther T. Sportel |
| 11 |
[GO] |
2021―Aug―02 |
Elevated INR in a COVID-19 patient after concomitant administration of favipiravir and warfarin: A case report |
Masao Sekimoto, Toru Imai, Shinji Hidaka, Nobutaka Chiba, Atsushi Sakurai, Mitsumasa Hata, Norikazu Kikuchi |
| 12 |
[GO] |
2021―Jul―13 |
Participation in ENSEMBLE phase III multicenter clinical trial of Ad26.CoV2.S, a COVID-19 vaccine: An investigational drug services perspective |
Nan Li |
| 13 |
[GO] |
2021―May―28 |
Improving COVID-19 vaccine-related health literacy and vaccine uptake in patients: Comparison on the readability of patient information leaflets of approved COVID-19 vaccines |
John E. Moore, Beverley C. Millar |
| 14 |
[GO] |
2021―May―08 |
Medication safety in a pandemic: A multicentre point prevalence study of QTc monitoring of hydroxychloroquine for COVID-19 |
Steven M. Smoke, Henry Leach, Nicole Leonida, Karan Raja, Monica Shah, Vishal Patel, Gargi Patel, Nicole M. Daniel, Jessica Gerges, Akshar Patel |
| 15 |
[GO] |
2021―Mar―26 |
QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19 |
Hui Moon Koh, Pei Feng Chong, Ju Nee Tan, Suresh Kumar Chidambaram, Hiu Jian Chua |
| 16 |
[GO] |
2021―Mar―26 |
The outcomes and acceptance of pressurized metered-dose inhaler bronchodilators with venturi mask modified spacer in the outpatient emergency department during the COVID-19 pandemic |
Hock Peng Koh, Nurul Shaliza Shamsudin, Marilyn May Yeen Tan, Zulsairi Mohd Pauzi |
| 17 |
[GO] |
2021―Mar―18 |
Safe handling and delivery of biological medications during the COVID-19 pandemic |
Amnah Mukhtar, Murooj Shukry, Douha Bannan |
| 18 |
[GO] |
2021―Mar―01 |
Repurposing functional inhibitors of acid sphingomyelinase (fiasmas): an opportunity against SARS-CoV-2 infection? |
Pascal Le Corre, Gwenolé Loas |
| 19 |
[GO] |
2021―Feb―27 |
Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study |
Inés Jiménez-Lozano, José Manuel Caro-Teller, Nuria Fernández-Hidalgo, Marta Miarons, Marie Antoinette Frick, Emma Batllori Badia, Berta Serrano, Carlos Javier Parramon-Teixidó, Fátima Camba-Longueira, Maria Teresa Moral-Pumarega, Rafael San Juan-Garrido, Maria Josep Cabañas Poy, Anna Suy, Maria Queralt Gorgas Torner |
| 20 |
[GO] |
2020―Dec―25 |
Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments |
Noemí Martínez-López-de-Castro, Marisol Samartín-Ucha, Adolfo Paradela-Carreiro, Antonio Pérez-Landeiro, María Teresa Inaraja-Bobo, Miriam Álvarez-Payero, Inés Castro-Núñez, Nerea García-Beloso, David Robles-Torres, Aida López-López, Sonia González-Costas, Belén Leboreiro-Enríquez, Luis Otero-Millán, Elena Yaiza Romero-Ventosa, Cristina Casanova-Martínez, Karina Lorenzo-Lorenzo, Ana María Regueira-Arcay, Cristina Vázquez-López, Cristina Martínez-Reglero, Guadalupe Piñeiro-Corrales |
| 21 |
[GO] |
2020―Nov―21 |
Breakthrough venous thromboembolic events in five patients with COVID-19 on direct oral anticoagulants |
Paul Lewis, Jennifer L. Tharp |
| 22 |
[GO] |
2020―Nov―21 |
The Zika virus: Lurking behind the COVID-19 pandemic? |
Joseph Pergolizzi, Jo Ann LeQuang, Sumiyo Umeda-Raffa, Charles Fleischer, Joseph Pergolizzi, Claudio Pergolizzi, Robert B. Raffa |
| 23 |
[GO] |
2020―Oct―31 |
Observational study of the effects of Favipiravir vs Lopinavir/Ritonavir on clinical outcomes in critically Ill patients with COVID-19 |
Havva Kocayiğit, Kezban Özmen Süner, Yakup Tomak, Gürkan Demir, Selçuk Yaylacı, Hamad Dheir, Ertuğrul Güçlü, Ali Fuat Erdem |
| 24 |
[GO] |
2020―Oct―26 |
Bone fractures during the time of coronavirus |
Sumiyo Umeda-Raffa, Joseph V. Pergolizzi Jr, Robert B. Raffa |
| 25 |
[GO] |
2020―Oct―24 |
Tocilizumab use in patients with moderate to severe COVID-19: A retrospective cohort study |
Sridhar Chilimuri, Haozhe Sun, Ahmed Alemam, Kyoung-Sil Kang, Peter Lao, Nikhitha Mantri, Lawrence Schiller, Myroslava Sharabun, Elona Shehi, Jairo Tejada, Alla Yugay, Suresh Kumar Nayudu |
| 26 |
[GO] |
2020―Oct―21 |
Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID-19) |
Bhitta Surapat, Somnuek Sungkanuparph, Suppachok Kirdlarp, Nantaporn Lekpittaya, Krittaya Chunnguleum |
| 27 |
[GO] |
2020―Sep―27 |
Chloroquine and hydroxychloroquine for COVID-19:
Perspectives on their failure in repurposing |
Rashmi R. Shah |
| 28 |
[GO] |
2020―Aug―29 |
Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19 |
Adeleh Sahebnasagh, Fatemeh Saghafi, Mohammadreza Safdari, Masoud Khataminia, Afsaneh Sadremomtaz, Zeinab Talaei, Hassan Rezai Ghaleno, Mahdi Bagheri, Solomon Habtemariam, Razieh Avan |
| 29 |
[GO] |
2020―Aug―08 |
Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis |
Jessica Barochiner, Rocío Martínez |
| 30 |
[GO] |
2020―Jul―31 |
Characteristics of Clinical Trials relating to COVID-19 registered at ClinicalTrials.gov |
Yuhui Wang, Qi Zhou, Mengqi Xu, Jian Kang, Yaolong Chen |
| 31 |
[GO] |
2020―Jul―21 |
QTc prolongation during antiviral therapy in two COVID-19 patients |
Suyan Zhu, Jian Wang, Yong Wang, Jinguo Chu, Yao Liu, Xueqin Chen, Xiaomin Chen |
| 32 |
[GO] |
2020―May―25 |
Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019 |
Qiuxiang Yang, Ling Xie, Wei Zhang, Lin Zhao, HuaJun Wu, Jie Jiang, Jili Zou, Jianguang Liu, Jun Wu, Yonggang Chen, Jinhu Wu |
|
